Heat Stress Tolerance in Plants

This invention proposes a method to make plants more resistant to (repeated) heat stress. This is done by means of using microRNA156 (miRNA156) to increase heat stress tolerance. miRNA156 is expressed under the control of a special heat-inducible promoter to minimize negative side effects such as enhanced leaf induction and later flowering. The proposed invention expresses miRNA156 exclusively by means of heat. The heat-inducible promoter HSP21 ensures that the expression of miR156 is “switched on” by
the application of heat.

Further information: PDF

ZAB ZukunftsAgentur Brandenburg GmbH Brainshell
Phone: +49 (0)331/200 29-262

Contact
Kerstin Nowak

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Combining robotics and ChatGPT

TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…

How the Immune System Learns from Harmless Particles

Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…

Biomarkers identified for successful treatment of bone marrow tumours

CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…

Partners & Sponsors